You just read:

National Cancer Centre Singapore, Singapore General Hospital and Clearbridge BioMedics Examine the Heterogeneity of CTCs in Breast Cancer Patients

News provided by

Clearbridge BioMedics

15 Apr, 2016, 09:00 ET